Teleflex Inc (TFX):企業の財務・戦略的SWOT分析

◆英語タイトル:Teleflex Inc (TFX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME810FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年3月
◆ページ数:68
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Teleflex Inc (TFX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Teleflex Inc (Teleflex) designs, develops, manufactures, and distributes disposable medical technology products for use in critical care and surgery. The company’s major products include circuits, masks and bags, endotracheal tubes, pain pumps, supraglottic airways, catheters, adaptor and connectors. Its products find application in fields such as vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex markets its products to hospitals, healthcare providers, distributors, and original equipment manufacturers through internal sales force, independent representatives and independent distributor networks. The company operates in the Americas, Europe, the Middle East, Africa and Asia. Teleflex is headquartered in Wayne, Pennsylvania, the US.

Teleflex Inc Key Recent Developments

Feb 24,2021: Teleflex announces submission of Biologics License Application for its investigational freeze dried plasma
Feb 16,2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
Feb 11,2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
Oct 29,2020: Teleflex reports third quarter 2020 results
Jul 30,2020: Teleflex reports second quarter 2020 results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Teleflex Inc – Key Facts
Teleflex Inc – Key Employees
Teleflex Inc – Key Employee Biographies
Teleflex Inc – Major Products and Services
Teleflex Inc – History
Teleflex Inc – Company Statement
Teleflex Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Teleflex Inc – Business Description
Product Category: Anesthesia
Performance
Product Category: Interventional
Performance
Product Category: Interventional Urology
Performance
Product Category: OEM
Overview
Performance
Performance
Product Category: Other
Performance
Product Category: Surgical
Performance
Product Category: Vascular Access
Performance
Product Category: Asia
Overview
Performance
Product Category: EMEA
Overview
Performance
Product Category: OEM
Overview
Performance
Performance
Product Category: The Americas
Overview
Performance
Geographical Segment: All Other
Performance
Geographical Segment: Asia Pacific
Performance
Geographical Segment: Europe
Performance
Geographical Segment: The US
Performance
R&D Overview
Teleflex Inc – Corporate Strategy
Teleflex Inc – SWOT Analysis
SWOT Analysis – Overview
Teleflex Inc – Strengths
Teleflex Inc – Weaknesses
Teleflex Inc – Opportunities
Teleflex Inc – Threats
Teleflex Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Teleflex Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Teleflex Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Teleflex Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 24, 2021: Teleflex announces submission of Biologics License Application for its investigational freeze dried plasma
Feb 16, 2021: Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
Feb 11, 2021: Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
Oct 29, 2020: Teleflex reports third quarter 2020 results
Jul 30, 2020: Teleflex reports second quarter 2020 results
Jun 23, 2020: Teleflex COVID 19 humanitarian product donation program
Apr 30, 2020: Teleflex reports first quarter 2020 results
Apr 29, 2020: Teleflex awarded Central Venous Access, Arterial Access agreements with Premier
Feb 20, 2020: Teleflex reports fourth quarter and full year 2019 results; provides 2020 guidance
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Teleflex Inc, Key Facts
Teleflex Inc, Key Employees
Teleflex Inc, Key Employee Biographies
Teleflex Inc, Major Products and Services
Teleflex Inc, History
Teleflex Inc, Other Locations
Teleflex Inc, Subsidiaries
Teleflex Inc, Key Competitors
Teleflex Inc, Ratios based on current share price
Teleflex Inc, Annual Ratios
Teleflex Inc, Annual Ratios (Cont...1)
Teleflex Inc, Annual Ratios (Cont...2)
Teleflex Inc, Interim Ratios
Teleflex Inc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Teleflex Inc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Teleflex Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Teleflex Inc (TFX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Integra Holdings Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Integra Holdings Ltd (Integra Holdings), a subsidiary of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, is a healthcare investment company that invests in biopharmaceutical companies with products in clinical and pre-clinical stages of development. The company …
  • Heat Biologics Inc (HTBX):企業の財務・戦略的SWOT分析
    Heat Biologics Inc (HTBX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hyundai Motor Co (005380):企業の財務・戦略的SWOT分析
    Hyundai Motor Co (005380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • G&K Services LLC:戦略・SWOT・企業財務分析
    G&K Services LLC - Strategy, SWOT and Corporate Finance Report Summary G&K Services LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Perilya Limited:企業の戦略・SWOT・財務情報
    Perilya Limited - Strategy, SWOT and Corporate Finance Report Summary Perilya Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Antibe Therapeutics Inc (ATE)-医療機器分野:企業M&A・提携分析
    Summary Antibe Therapeutics Inc (Antibe) is a biotechnology company that designs and develops drug candidates for chronic pain and inflammation; and regenerative medicine. The company discovers and commercialize novel drugs, biologics and medical devices. It offers lead compound ATB-346, a naproxen …
  • NEX Group plc. (IAP):企業の戦略的SWOT分析
    NEX Group plc. (IAP) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Calumet Specialty Products Partners LP (CLMT):企業の財務・戦略的SWOT分析
    Calumet Specialty Products Partners LP (CLMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Nippon Soda Co., Ltd.:企業の戦略・SWOT・財務情報
    Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Nippon Soda Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Flextronics International Ltd.:戦略・SWOT・企業財務分析
    Flextronics International Ltd. - Strategy, SWOT and Corporate Finance Report Summary Flextronics International Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Great Portland Estates Plc (GPOR):企業の財務・戦略的SWOT分析
    Great Portland Estates Plc (GPOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bioorganic Research and Services SA (BNT):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioorganic Research and Services SA (Bionaturis) is a biotechnology company that develops non-prescription products for production animals and pets. The company offers products such as BNT006, BNT007, BNT010, BNT015 and BNT005. It provides non-therapeutic and therapeutic products for poultry …
  • Red Rock Resorts, Inc. (RRR):企業の財務・戦略的SWOT分析
    Red Rock Resorts, Inc. (RRR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Playboy Enterprises Inc:企業の戦略的SWOT分析
    Playboy Enterprises Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • HealthCare Global Enterprises Ltd (HCG):製薬・医療:M&Aディール及び事業提携情報
    Summary HealthCare Global Enterprises Ltd (HCG), formerly Curie Centre of Oncology Private Ltd is a healthcare service provider that provides medical care and treatment services. The company provides services such as clinical laboratory services, diagnosis services, medical oncology services, radiat …
  • Granite REIT (GRT.UN):企業の財務・戦略的SWOT分析
    Summary Granite REIT (Granite), formerly Granite Real Estate Inc is a construction company that offers real estate investment services. The company acquires, develops, constructs and manages industrial properties. It offers services such as site development, re-zoning to specific uses, assisting wit …
  • America Movil, SA DE C.V.:企業の戦略・SWOT・財務情報
    America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report Summary America Movil, SA DE C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • National Institutes of Health:企業のM&A・事業提携・投資動向
    National Institutes of Health - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's National Institutes of Health Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Astra Microwave Products Limited:企業の戦略・SWOT・財務情報
    Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report Summary Astra Microwave Products Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • 2-BBB Medicines BV:製薬・医療:M&Aディール及び事業提携情報
    Summary 2-BBB Medicines BV (2-BBB), formerly to-BBB Therapeutics BV is a biotechnology company that develops medicines for the treatment of brain cancer and neuro-inflammatory diseases. The company develops medicines using its proprietary liposomal drug delivery platform, G-Technology. Its pipeline …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆